Cook, E B <br/><br/>
Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells.  [electronic resource] 

 -  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology  Nov 2001 
 - 424-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1081-1206 
<br/><br/><label>Standard No.: </label>10.1016/S1081-1206(10)62926-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Allergic Agents--pharmacology<br/>Antibodies, Anti-Idiotypic--pharmacology<br/>Cells, Cultured<br/>Conjunctiva--cytology<br/>Conjunctivitis, Allergic--immunology<br/>Culture Media, Conditioned--pharmacology<br/>Dibenzoxepins--pharmacology<br/>Dose-Response Relationship, Drug<br/>Drug Antagonism<br/>Epithelial Cells--drug effects<br/>Histamine H1 Antagonists--pharmacology<br/>Humans<br/>Intercellular Adhesion Molecule-1--biosynthesis<br/>Mast Cells--drug effects<br/>Olopatadine Hydrochloride<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Up-Regulation